logo
  • Home
  • Technologies
    • Live Cell Encapsulation
    • Research & Development
    • Cancer
    • Diabetes
    • Cannabinoids
  • Company
    • Management
    • Board of Directors
    • Governance
    • Medical and Scientific Advisory Board
    • International Diabetes Consortium
  • Investors
    • Overview
    • News / Events
    • Shareholder Calls/Updates
    • Presentations
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • News & Media
    • Press Releases
    • Presentations
    • Articles
    • Reports
    • Media
    • Photo Gallery
  • Contact
    • Social Media Community Guidelines

Media

    • 10 JAN 2022
  • 2022 H.C. Wainwright BioConnect Conference

    WEBCAST

    • Posted in
    • Media
    • 30 JUN 2021
  • PharmaCyte Biotech, Inc. Annual Meeting of Shareholders June 30, 2021

    https://pharmacyte.com/wp-content/uploads/2021/07/ShareHolderCall30June2021.mp4
    • Posted in
    • Media
    • 16 JUN 2021
  • PharmaCyte Biotech, Inc. Annual Meeting of Shareholders June 16, 2021

    https://pharmacyte.com/wp-content/uploads/2021/06/ShareHolderCall17June2021.mp4
    • Posted in
    • Media
    • 25 JUN 2019
  • Interview with PharmaCyte’s Chief Executive Officer, Kenneth L. Waggoner, at the GMP Facility

    Interview with Austrianova’s Walter H. Gunzburg at the GMP Facility

    GMP Manufacturing Facility Walkthrough

    • Posted in
    • Media
    • 22 JAN 2019
  • CEO Interview: The Big Biz Show

    • Posted in
    • Media
    • 30 MAY 2018
  • PharmaCyte Biotech Interview with Chief Executive Officer and Chief Scientific Officer – May 30, 2018

    Click to listen →

    • Posted in
    • Media
    • 06 JUL 2017
  • 2017 Presentation to Oncologists and Interviews from ASCO Meeting Event in Chicago

    Presentation Video:

    Dr. Lohr Interview:

    Dr. Crabtree Interview:

    • Posted in
    • Media
    • 21 JUN 2017
  • 2017 BIO International Conference Buzz of BIO “Pipelines of Promise” Award Winner Presentation

    • Posted in
    • Media
    • 05 SEP 2016
  • CEO/CFO Magazine Interview with PharmaCyte CEO & COO

    • Posted in
    • Media
    • 02 AUG 2016
  • Medical Cannabis for Cancer By Mark L. Rabe, MD

    • Posted in
    • Media
    • 23 JUN 2016
  • 2016 Medical and Scientific Presentations to Clinical Oncologists at ASCO

    As PharmaCyte Biotech heads into the final preparations for its Phase 2b clinical trial in advanced pancreatic cancer, the company hosted a medical and scientific discussion of our therapy for advanced pancreatic cancer among top oncologist investigators who have expressed interest in PharmaCyte’s technology and participation in the Phase 2b clinical trial. Below you will find the 5 presentations that were delivered to those invited oncologists. After Dr. Manuel Hidalgo, a member of PharmaCyte’s medical and scientific advisory board, completed his presentation of the design of the upcoming Phase 2b clinical trial, an hour-long discussion took place between those invited oncologists and those representing PharmaCyte Biotech; Dr. Matthias Löhr, Dr. Manuel Hidalgo, Prof. Dr. Walter H. Günzburg, and Dr. Brian Salmons.

Contact Us

PharmaCyte Biotech Inc.
3960 Howard Hughes Parkway, Suite 500
Las Vegas, Nevada 89169
Office Number: 917.595.2850
Facsimile Number: 917.595.2851
Email: info@PharmaCyte.com

  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS

Latest News

  • PharmaCyte Biotech to Attend 15th International Conference on Advanced Technologies and Treatments for Diabetes 2022-04-27T09:00:24-0400
  • PharmaCyte Biotech Announces More Positive Tests Results for Its Pancreatic Cancer Clinical Trial Product Candidate to Satisfy FDA Requirements 2022-04-19T08:45:42-0400

Subscribe to Our Mailing List

* indicates required
Email Format